| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T15 |
0-8 |
DISEASE |
denotes |
Down-reg |
| T39 |
0-8 |
DISEASE |
denotes |
Down-reg |
| T0 |
0-14 |
NEGREG |
denotes |
Down-regulated |
| T9 |
1-9 |
DISEASE |
denotes |
own-regu |
| T1 |
20-30 |
MPA |
denotes |
expression |
| T2 |
44-60 |
CPA |
denotes |
immune responses |
| T3 |
61-68 |
REG |
denotes |
changed |
| T5 |
103-111 |
DISEASE |
denotes |
COVID-19 |
| T6 |
136-146 |
DISEASE |
denotes |
O characte |
| T7 |
148-156 |
DISEASE |
denotes |
zes nove |
| T10 |
189-195 |
REG |
denotes |
caused |
| T11 |
311-326 |
MPA |
denotes |
cytokine levels |
| T12 |
340-347 |
DISEASE |
denotes |
rtion a |
| T13 |
363-373 |
MPA |
denotes |
expression |
| T14 |
374-383 |
REG |
denotes |
occurring |
| T16 |
427-434 |
DISEASE |
denotes |
intial |
| T17 |
480-488 |
DISEASE |
denotes |
COVID-19 |
| T20 |
613-623 |
DISEASE |
denotes |
expressio |
| T21 |
614-624 |
MPA |
denotes |
expression |
| T22 |
663-678 |
GENE |
denotes |
severe patients |
| T23 |
694-699 |
DISEASE |
denotes |
Cough |
| T24 |
704-709 |
CPA |
denotes |
fever |
| T25 |
713-718 |
GENE |
denotes |
e the |
| T26 |
742-752 |
DISEASE |
denotes |
COVID-2019 |
| T27 |
775-778 |
POSREG |
denotes |
mor |
| T29 |
804-810 |
POSREG |
denotes |
higher |
| T30 |
811-835 |
MPA |
denotes |
C-reactive protein level |
| T31 |
841-846 |
REG |
denotes |
found |
| T32 |
841-849 |
DISEASE |
denotes |
found in |
| T33 |
870-875 |
MPA |
denotes |
level |
| T34 |
894-900 |
REG |
denotes |
varied |
| T35 |
945-954 |
NEGREG |
denotes |
decreased |
| T36 |
955-973 |
CPA |
denotes |
T cell proportions |
| T37 |
971-976 |
GENE |
denotes |
ns we |
| T38 |
979-987 |
REG |
denotes |
observed |
| T40 |
1025-1029 |
GENE |
denotes |
vere |
| T41 |
1105-1109 |
GENE |
denotes |
ut o |
| T42 |
1113-1124 |
CPA |
denotes |
CD4+T cells |
| T43 |
1173-1174 |
REG |
denotes |
D |
| T44 |
1174-1175 |
REG |
denotes |
E |
| T45 |
1178-1187 |
POSREG |
denotes |
increased |
| T46 |
1219-1228 |
NEGREG |
denotes |
decreased |
| T47 |
1232-1238 |
GENE |
denotes |
er ini |
| T48 |
1243-1247 |
GENE |
denotes |
trea |
| T49 |
1258-1272 |
NEGREG |
denotes |
down-regulated |
| T50 |
1301-1309 |
REG |
denotes |
involved |
| T51 |
1313-1338 |
CPA |
denotes |
Th17 cell differentiation |
| T52 |
1340-1375 |
PATHWAY |
denotes |
cytokine-mediated signaling pathway |
| T53 |
1380-1397 |
CPA |
denotes |
T cell activation |
| T54 |
1439-1445 |
GENE |
denotes |
MAP2K7 |
| T55 |
1450-1454 |
GENE |
denotes |
SOS1 |
| T57 |
1460-1468 |
DISEASE |
denotes |
upregula |
| T56 |
1460-1471 |
POSREG |
denotes |
upregulated |
| T58 |
1536-1545 |
NEGREG |
denotes |
decreased |
| T59 |
1541-1549 |
DISEASE |
denotes |
ased T c |
| T60 |
1546-1563 |
CPA |
denotes |
T cell proportion |
| T61 |
1569-1583 |
NEGREG |
denotes |
down-regulated |
| T62 |
1589-1599 |
MPA |
denotes |
expression |
| T63 |
1611-1628 |
CPA |
denotes |
T cell activation |
| T64 |
1633-1648 |
CPA |
denotes |
differentiation |
| T65 |
1654-1662 |
REG |
denotes |
occurred |
| T66 |
1666-1674 |
DISEASE |
denotes |
COVID-19 |
| T67 |
1728-1737 |
CPA |
denotes |
treatment |
| T68 |
1753-1761 |
DISEASE |
denotes |
COVID-19 |
| R0 |
T1 |
T0 |
ThemeOf |
expression,Down-regulated |
| R1 |
T1 |
T3 |
ThemeOf |
expression,changed |
| R10 |
T15 |
T13 |
ThemeOf |
Down-reg,expression |
| R11 |
T15 |
T14 |
ThemeOf |
Down-reg,occurring |
| R14 |
T30 |
T29 |
ThemeOf |
C-reactive protein level,higher |
| R15 |
T30 |
T31 |
ThemeOf |
C-reactive protein level,found |
| R16 |
T33 |
T34 |
ThemeOf |
level,varied |
| R17 |
T36 |
T35 |
ThemeOf |
T cell proportions,decreased |
| R18 |
T36 |
T38 |
ThemeOf |
T cell proportions,observed |
| R19 |
T39 |
T35 |
ThemeOf |
Down-reg,decreased |
| R2 |
T2 |
T0 |
ThemeOf |
immune responses,Down-regulated |
| R20 |
T39 |
T38 |
ThemeOf |
Down-reg,observed |
| R21 |
T44 |
T43 |
ThemeOf |
E,D |
| R22 |
T44 |
T45 |
ThemeOf |
E,increased |
| R23 |
T51 |
T49 |
ThemeOf |
Th17 cell differentiation,down-regulated |
| R24 |
T51 |
T50 |
ThemeOf |
Th17 cell differentiation,involved |
| R25 |
T52 |
T50 |
ThemeOf |
cytokine-mediated signaling pathway,involved |
| R26 |
T53 |
T50 |
ThemeOf |
T cell activation,involved |
| R27 |
T54 |
T56 |
ThemeOf |
MAP2K7,upregulated |
| R28 |
T55 |
T56 |
ThemeOf |
SOS1,upregulated |
| R29 |
T58 |
T61 |
CauseOf |
decreased,down-regulated |
| R3 |
T2 |
T3 |
ThemeOf |
immune responses,changed |
| R30 |
T60 |
T58 |
ThemeOf |
T cell proportion,decreased |
| R31 |
T60 |
T61 |
ThemeOf |
T cell proportion,down-regulated |
| R32 |
T60 |
T62 |
ThemeOf |
T cell proportion,expression |
| R33 |
T60 |
T65 |
ThemeOf |
T cell proportion,occurred |
| R34 |
T62 |
T61 |
ThemeOf |
expression,down-regulated |
| R35 |
T62 |
T58 |
ThemeOf |
expression,decreased |
| R36 |
T64 |
T62 |
ThemeOf |
differentiation,expression |
| R37 |
T62 |
T65 |
ThemeOf |
expression,occurred |
| R38 |
T63 |
T58 |
ThemeOf |
T cell activation,decreased |
| R39 |
T63 |
T61 |
ThemeOf |
T cell activation,down-regulated |
| R4 |
T5 |
T3 |
ThemeOf |
COVID-19,changed |
| R40 |
T63 |
T62 |
ThemeOf |
T cell activation,expression |
| R41 |
T63 |
T65 |
ThemeOf |
T cell activation,occurred |
| R42 |
T64 |
T58 |
ThemeOf |
differentiation,decreased |
| R43 |
T64 |
T61 |
ThemeOf |
differentiation,down-regulated |
| R44 |
T64 |
T65 |
ThemeOf |
differentiation,occurred |
| R45 |
T66 |
T58 |
ThemeOf |
COVID-19,decreased |
| R46 |
T66 |
T61 |
ThemeOf |
COVID-19,down-regulated |
| R47 |
T66 |
T65 |
ThemeOf |
COVID-19,occurred |
| R48 |
T68 |
T67 |
ThemeOf |
COVID-19,treatment |
| R6 |
T9 |
T10 |
ThemeOf |
own-regu,caused |
| R7 |
T11 |
T13 |
ThemeOf |
cytokine levels,expression |
| R8 |
T11 |
T14 |
ThemeOf |
cytokine levels,occurring |
| R9 |
T13 |
T14 |
ThemeOf |
expression,occurring |
